American Journal of Public Health
Table of Contents for American Journal of Public Health
Table of Contents for American Journal of Public Health
Emily Whitehead has been in remission since 2012 after receiving CAR T-cell therapy to treat her leukemia.
This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value enter…
Chimeric antigen receptor T-cell therapy (CAR-T) has revolutionized the management of relapsed and/or refractory multiple myeloma (RRMM). However, CAR-T treatment failure is not uncommon and…
“Today’s unanimous ODAC vote – 12-0 in favor – is a milestone for the field of multiple myeloma,” said Dr. C. Ola Landgren, director of…
Although 64% of patients seeking IO consultation reported clinically significant SD, only 11% were seeking integrative approaches for managing SD. ESAS fatigue, hot flashes, well-being,…
By using this website, you consent to us using cookies as described in this policy
Blood Cancer Journal – Like a bridge over troubled water: keeping the myeloma down en route to CAR-T
About 15 years ago, Carl Ola Landgren, M.D. Ph.D., noticed an encouraging yet potentially concerning trend in the treatment of multiple myeloma. | At an…
Traditional prognostic models for newly diagnosed patients with multiple myeloma (MM), including International Staging System criteria and number of high-risk chromosomal abnormalities, are based on…
Chimeric antigen receptor-modified T cell (CAR-T) therapy has become a critical part of the armamentarium for the treatment of relapsed/refractory hematologic malignancies. As our experience…